Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Validation of a decision-analytic model for the cost-effectiveness analysis of a risk-stratified National Breast Screening Programme in the United Kingdom

View ORCID ProfileStuart J Wright, Ewan Gray, View ORCID ProfileGabriel Rogers, Anna Donten, View ORCID ProfileKatherine Payne
doi: https://doi.org/10.1101/2022.12.05.22283099
Stuart J Wright
1Manchester Centre for Health Economics, Division of Population Health, Health Services Research & Primary Care, The University of Manchester, Oxford Road, Manchester, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Stuart J Wright
  • For correspondence: stuart.j.wright{at}manchester.ac.uk
Ewan Gray
1Manchester Centre for Health Economics, Division of Population Health, Health Services Research & Primary Care, The University of Manchester, Oxford Road, Manchester, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gabriel Rogers
1Manchester Centre for Health Economics, Division of Population Health, Health Services Research & Primary Care, The University of Manchester, Oxford Road, Manchester, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Gabriel Rogers
Anna Donten
1Manchester Centre for Health Economics, Division of Population Health, Health Services Research & Primary Care, The University of Manchester, Oxford Road, Manchester, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Katherine Payne
1Manchester Centre for Health Economics, Division of Population Health, Health Services Research & Primary Care, The University of Manchester, Oxford Road, Manchester, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Katherine Payne
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Article usage

Article usage: December 2022 to June 2025

AbstractFullPdf
Dec 20223661361
Jan 202391630
Feb 202354120
Mar 202324210
Apr 20232617
May 20231315
Jun 20232056
Jul 202334210
Aug 202329149
Sep 202338616
Oct 20231666
Nov 202330115
Dec 20232304
Jan 20241933
Feb 20242309
Mar 202416015
Apr 2024112122
May 20241635
Jun 20241919
Jul 202416511
Aug 20241774
Sep 202421126
Oct 20241236
Nov 202422312
Dec 20241239
Jan 20252406
Feb 202519282
Mar 2025185016
Apr 202521109
May 2025361417
Jun 202525915
Back to top
PreviousNext
Posted December 05, 2022.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Validation of a decision-analytic model for the cost-effectiveness analysis of a risk-stratified National Breast Screening Programme in the United Kingdom
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Validation of a decision-analytic model for the cost-effectiveness analysis of a risk-stratified National Breast Screening Programme in the United Kingdom
Stuart J Wright, Ewan Gray, Gabriel Rogers, Anna Donten, Katherine Payne
medRxiv 2022.12.05.22283099; doi: https://doi.org/10.1101/2022.12.05.22283099
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools
Validation of a decision-analytic model for the cost-effectiveness analysis of a risk-stratified National Breast Screening Programme in the United Kingdom
Stuart J Wright, Ewan Gray, Gabriel Rogers, Anna Donten, Katherine Payne
medRxiv 2022.12.05.22283099; doi: https://doi.org/10.1101/2022.12.05.22283099

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Health Economics
Subject Areas
All Articles
  • Addiction Medicine (349)
  • Allergy and Immunology (668)
  • Allergy and Immunology (668)
  • Anesthesia (181)
  • Cardiovascular Medicine (2648)
  • Dentistry and Oral Medicine (316)
  • Dermatology (223)
  • Emergency Medicine (399)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (942)
  • Epidemiology (12228)
  • Forensic Medicine (10)
  • Gastroenterology (759)
  • Genetic and Genomic Medicine (4103)
  • Geriatric Medicine (387)
  • Health Economics (680)
  • Health Informatics (2657)
  • Health Policy (1005)
  • Health Systems and Quality Improvement (985)
  • Hematology (363)
  • HIV/AIDS (851)
  • Infectious Diseases (except HIV/AIDS) (13695)
  • Intensive Care and Critical Care Medicine (797)
  • Medical Education (399)
  • Medical Ethics (109)
  • Nephrology (436)
  • Neurology (3882)
  • Nursing (209)
  • Nutrition (577)
  • Obstetrics and Gynecology (739)
  • Occupational and Environmental Health (695)
  • Oncology (2030)
  • Ophthalmology (585)
  • Orthopedics (240)
  • Otolaryngology (306)
  • Pain Medicine (250)
  • Palliative Medicine (75)
  • Pathology (473)
  • Pediatrics (1115)
  • Pharmacology and Therapeutics (466)
  • Primary Care Research (452)
  • Psychiatry and Clinical Psychology (3432)
  • Public and Global Health (6527)
  • Radiology and Imaging (1403)
  • Rehabilitation Medicine and Physical Therapy (814)
  • Respiratory Medicine (871)
  • Rheumatology (409)
  • Sexual and Reproductive Health (410)
  • Sports Medicine (342)
  • Surgery (448)
  • Toxicology (53)
  • Transplantation (185)
  • Urology (165)